title: Treatment pathways and resource use associated with recurrent Hodgkin lymphoma after autologous stem cell transplantation.
authors.affiliation: The University of Manchester and the Christie NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.
authors.forename: J
authors.initials: J
authors.lastname: Radford
authors.affiliation: The Beatson West of Scotland Cancer Centre, Glasgow, Scotland.
authors.forename: P
authors.initials: P
authors.lastname: McKay
authors.affiliation: Queen Elizabeth Hospital, Birmingham, UK.
authors.forename: R
authors.initials: R
authors.lastname: Malladi
authors.affiliation: St James' Hospital, Leeds, UK.
authors.forename: R
authors.initials: R
authors.lastname: Johnson
authors.affiliation: The Christie NHS Foundation Trust, Manchester, UK.
authors.forename: A
authors.initials: A
authors.lastname: Bloor
authors.affiliation: pH Associates, Marlow, UK.
authors.forename: F
authors.initials: F
authors.lastname: Percival
authors.affiliation: Addenbrooke's Hospital, Cambridge, UK.
authors.forename: A
authors.initials: A
authors.lastname: Sureda
authors.affiliation: University College London Hospitals NHS Foundation Trust, University College London Cancer Institute, London, UK.
authors.forename: K S
authors.initials: KS
authors.lastname: Peggs
mesh_terms: D064592:Autografts; D003365:Costs and Cost Analysis; D005260:Female; D006689:Hodgkin Disease / Q000191:economics* / Q000401:mortality / Q000628:therapy; D006801:Humans; D008297:Male; D033581:Stem Cell Transplantation / Q000191:economics*